-
1
-
-
0034307229
-
A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
-
Bristow RE, Duska LR, Lambrou NC, Fishman EK, O'Neill MJ, Trimble EL, et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer. 2000;89:1532-40.
-
(2000)
Cancer.
, vol.89
, pp. 1532-1540
-
-
Bristow, R.E.1
Duska, L.R.2
Lambrou, N.C.3
Fishman, E.K.4
O'Neill, M.J.5
Trimble, E.L.6
-
2
-
-
79952418462
-
Epidemiological characteristics of ovarian cancer in Korea
-
Park B, Park S, Kim TJ, Ma SH, Kim BG, Kim YM, et al. Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol. 2010;21:241-7.
-
(2010)
J Gynecol Oncol
, vol.21
, pp. 241-247
-
-
Park, B.1
Park, S.2
Kim, T.J.3
Ma, S.H.4
Kim, B.G.5
Kim, Y.M.6
-
4
-
-
77953461995
-
A hospital-based case-control study of identifying ovarian cancer using symptom index
-
Kim MK, Kim K, Kim SM, Kim JW, Park NH, Song YS, et al. A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol. 2009;20:238-42.
-
(2009)
J Gynecol Oncol.
, vol.20
, pp. 238-242
-
-
Kim, M.K.1
Kim, K.2
Kim, S.M.3
Kim, J.W.4
Park, N.H.5
Song, Y.S.6
-
5
-
-
33846245932
-
Development of an ovarian cancer symptom index: Possibilities for earlier detection
-
DOI 10.1002/cncr.22371
-
Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109:221-7. (Pubitemid 46106236)
-
(2007)
Cancer
, vol.109
, Issue.2
, pp. 221-227
-
-
Goff, B.A.1
Mandel, L.S.2
Drescher, C.W.3
Urban, N.4
Gough, S.5
Schurman, K.M.6
Patras, J.7
Mahony, B.S.8
Robyn Andersen, M.9
-
6
-
-
0021905171
-
The role of CT in the evaluation of ovarian malignancy
-
Amendola MA. The role of CT in the evaluation of ovarian malignancy. Crit Rev Diagn Imaging. 1985;24:329-68.
-
(1985)
Crit Rev Diagn Imaging
, vol.24
, pp. 329-368
-
-
Amendola, M.A.1
-
8
-
-
33947218828
-
18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: Correlation with clinical or histological findings
-
DOI 10.1007/s00259-006-0260-x
-
18FFDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. Eur J Nucl Med Mol Imaging. 2007;34:480-6. (Pubitemid 46426988)
-
(2007)
European Journal of Nuclear Medicine and Molecular Imaging
, vol.34
, Issue.4
, pp. 480-486
-
-
Chung, H.H.1
Kang, W.J.2
Kim, J.W.3
Park, N.-H.4
Song, Y.-S.5
Chung, J.-K.6
Kang, S.-B.7
Lee, H.-P.8
-
9
-
-
52449111259
-
Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: Comparison with enhanced CT
-
Kitajima K, Murakami K, Yamasaki E, Kaji Y, Fukasawa I, Inaba N, et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging. 2008;35:1912-20.
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 1912-1920
-
-
Kitajima, K.1
Murakami, K.2
Yamasaki, E.3
Kaji, Y.4
Fukasawa, I.5
Inaba, N.6
-
11
-
-
0033931766
-
Use of PET to monitor the response of lung cancer to radiation treatment
-
Erdi YE, Macapinlac H, Rosenzweig KE, Humm JL, Larson SM, Erdi AK, et al. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med. 2000;27:861-6. (Pubitemid 30456770)
-
(2000)
European Journal of Nuclear Medicine
, vol.27
, Issue.7
, pp. 861-866
-
-
Erdi, Y.E.1
Macapinlac, H.2
Rosenzweig, K.E.3
Humm, J.L.4
Larson, S.M.5
Erdi, A.K.6
Yorke, E.D.7
-
12
-
-
48149102304
-
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: Comparison with integrated FDG-PET/non-contrast- enhanced CT and enhanced CT
-
Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Fukasawa I, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast- enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging. 2008;35:1439-48.
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 1439-1448
-
-
Kitajima, K.1
Murakami, K.2
Yamasaki, E.3
Domeki, Y.4
Kaji, Y.5
Fukasawa, I.6
-
13
-
-
77956794299
-
Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels
-
Bhosale P, Peungjesada S, Wei W, Levenback CF, Schmeler K, Rohren E, et al. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010;20:936-44.
-
(2010)
Int J Gynecol Cancer
, vol.20
, pp. 936-944
-
-
Bhosale, P.1
Peungjesada, S.2
Wei, W.3
Levenback, C.F.4
Schmeler, K.5
Rohren, E.6
-
14
-
-
79952657079
-
Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer
-
Risum S, Loft A, Hogdall C, Berthelsen AK, Hogdall E, Lundvall L, et al. Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer. Acta Oncol. 2011;50:415-9.
-
(2011)
Acta Oncol.
, vol.50
, pp. 415-419
-
-
Risum, S.1
Loft, A.2
Hogdall, C.3
Berthelsen, A.K.4
Hogdall, E.5
Lundvall, L.6
-
15
-
-
75949102368
-
Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?
-
Risum S, Hogdall C, Loft A, Berthelsen AK, Hogdall E, Ne-dergaard L, et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol. 2010;116:395-8.
-
(2010)
Gynecol Oncol
, vol.116
, pp. 395-398
-
-
Risum, S.1
Hogdall, C.2
Loft, A.3
Berthelsen, A.K.4
Hogdall, E.5
Ne-Dergaard, L.6
-
16
-
-
34548552737
-
18F-FDG PET scans
-
DOI 10.2967/jnumed.107.042333
-
18F-FDG PET scans. J Nucl Med. 2007;48:1449-58. (Pubitemid 47397395)
-
(2007)
Journal of Nuclear Medicine
, vol.48
, Issue.9
, pp. 1449-1458
-
-
Francis, R.J.1
Byrne, M.J.2
Van Der Schaaf, A.A.3
Boucek, J.A.4
Nowak, A.K.5
Phillips, M.6
Price, R.7
Patrikeos, A.P.8
Musk, A.W.9
Millward, M.J.10
-
17
-
-
75749132383
-
Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma
-
Veit-Haibach P, Schaefer NG, Steinert HC, Soyka JD, Seifert B, Stahel RA. Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer. 2010;67:311-7.
-
(2010)
Lung Cancer
, vol.67
, pp. 311-317
-
-
Veit-Haibach, P.1
Schaefer, N.G.2
Steinert, H.C.3
Soyka, J.D.4
Seifert, B.5
Stahel, R.A.6
-
18
-
-
0018079655
-
Basic principles of ROC analysis
-
Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283-98. (Pubitemid 9075026)
-
(1978)
Seminars in Nuclear Medicine
, vol.8
, Issue.4
, pp. 283-298
-
-
Metz, C.E.1
-
19
-
-
56949099284
-
Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histo-pathologic and clinical response evaluation
-
Roedl JB, Colen RR, Holalkere NS, Fischman AJ, Choi NC, Blake MA. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histo-pathologic and clinical response evaluation. Radiother Oncol. 2008;89:278-86.
-
(2008)
Radiother Oncol
, vol.89
, pp. 278-286
-
-
Roedl, J.B.1
Colen, R.R.2
Holalkere, N.S.3
Fischman, A.J.4
Choi, N.C.5
Blake, M.A.6
-
20
-
-
70349466802
-
18F-fluorodeoxyglucose Positron Emission Tomographycomputed Tomography Predicts Short-term Outcome to Radiotherapy with or Without Chemotherapy in Pha-ryngeal Cancer
-
18F-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pha-ryngeal cancer. Clin Cancer Res. 2009;15:5861-8.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 5861-5868
-
-
Chung, M.K.1
Jeong, H.S.2
Park, S.G.3
Jang, J.Y.4
Son, Y.I.5
Choi, J.Y.6
-
21
-
-
67651089991
-
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer
-
La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, et al. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009; 74:1335-41.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 1335-1341
-
-
La, T.H.1
Filion, E.J.2
Turnbull, B.B.3
Chu, J.N.4
Lee, P.5
Nguyen, K.6
-
23
-
-
70449602154
-
18F-FDG uptake on positron emission tomography in patients with pathologic stage i non-small cell lung cancer
-
18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer. J Thorac Oncol. 2009;4:1331-6.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1331-1336
-
-
Um, S.W.1
Kim, H.2
Koh, W.J.3
Suh, G.Y.4
Chung, M.P.5
Kwon, O.J.6
-
24
-
-
20444401200
-
Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging
-
Steinert HC, Santos Dellea MM, Burger C, Stahel R. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging. Lung Cancer. 2005;49(Suppl 1): S33-5.
-
(2005)
Lung Cancer.
, vol.49
, Issue.SUPPL. 1
-
-
Steinert, H.C.1
Santos Dellea, M.M.2
Burger, C.3
Stahel, R.4
-
25
-
-
3042517468
-
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining longterm outcomes of rectal cancer
-
DOI 10.1016/j.jamcollsurg.2004.02.024, PII S107275150400290X
-
Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preop-erative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg. 2004;199:1-7. (Pubitemid 38813288)
-
(2004)
Journal of the American College of Surgeons
, vol.199
, Issue.1
, pp. 1-7
-
-
Guillem, J.G.1
Moore, H.G.2
Akhurst, T.3
Klimstra, D.S.4
Ruo, L.5
Mazumdar, M.6
Minsky, B.D.7
Saltz, L.8
Wong, W.D.9
Larson, S.10
-
26
-
-
42449118429
-
Bone metastases in patients with metastatic breast cancer: Morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT
-
Tateishi U, Gamez C, Dawood S, Yeung HW, Cristofanilli M, Macapinlac HA. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. Radiology. 2008; 247:189-96.
-
(2008)
Radiology
, vol.247
, pp. 189-196
-
-
Tateishi, U.1
Gamez, C.2
Dawood, S.3
Yeung, H.W.4
Cristofanilli, M.5
MacApinlac, H.A.6
-
27
-
-
79251601258
-
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
-
Chung HH, Kim JW, Han KH, Eo JS, Kang KW, Park NH, et al. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. Gynecol Oncol. 2011; 120:270-4.
-
(2011)
Gynecol Oncol
, vol.120
, pp. 270-274
-
-
Chung, H.H.1
Kim, J.W.2
Han, K.H.3
Eo, J.S.4
Kang, K.W.5
Park, N.H.6
-
28
-
-
6944235697
-
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study
-
Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004; 45:1519-27. (Pubitemid 47618506)
-
(2004)
Journal of Nuclear Medicine
, vol.45
, Issue.9
, pp. 1519-1527
-
-
Boellaard, R.1
Krak, N.C.2
Hoekstra, O.S.3
Lammertsma, A.A.4
-
29
-
-
0028784446
-
SUV: Standard uptake or silly useless value?
-
Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836-9.
-
(1995)
J Nucl Med
, vol.36
, pp. 1836-1839
-
-
Keyes Jr., J.W.1
-
30
-
-
33847159680
-
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: Effects of image reconstruction, resolution and ROI definition parameters
-
DOI 10.1007/s00259-006-0224-1
-
Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34:392-404. (Pubitemid 46295349)
-
(2007)
European Journal of Nuclear Medicine and Molecular Imaging
, vol.34
, Issue.3
, pp. 392-404
-
-
Westerterp, M.1
Pruim, J.2
Oyen, W.3
Hoekstra, O.4
Paans, A.5
Visser, E.6
Van Lanschot, J.7
Sloof, G.8
Boellaard, R.9
|